Market Data 
Markets
Replies to post #72978 on Biotech Values
02/10/09 6:31 AM
02/10/09 6:33 AM
“It’s much harder to reverse-engineer a biologic than to make a new biologic… we see many players stating that they’re going to enter the follow-on biologics business, but we see very few with clearly defined or clearly differentiated strategies. Our view is that you need to have a differentiated strategy… that’s what we’re going after: …technology differentiation through characterization”
AI
